CSTONE PHARMACEUTICALS

cstone-pharmaceuticals-logo

CStone Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing innovative tumor immunotherapy and precision treatment drugs to meet the intensive medical needs of cancer patients in China and around the world.CStone Pharmaceuticals has assembled a world-class management team with extensive experience in new drug development, clinical research, and commercialization. The company has built a rich product pipeline composed of 15 tumor candidate drugs with the combination of tumor immunotherapy as the core.

#SimilarOrganizations #People #Financial #Website #More

CSTONE PHARMACEUTICALS

Social Links:

Industry:
Biotechnology Health Care Medical Pharmaceutical

Founded:
2015-12-23

Address:
Suzhou, Jiangsu, China

Country:
China

Website Url:
http://www.cstonepharma.com

Total Employee:
101+

Status:
Active

Contact:
+ 86-(0)512-8718-6550

Email Addresses:
[email protected]

Total Funding:
410 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Mobile Non Scaleable Content Euro Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS IIS


Similar Organizations

botanix-pharmaceuticals-logo

Botanix Pharmaceuticals

Botanix Pharmaceuticals is a pharmaceutical company that focuses on the treatment of skin diseases.

celator-pharmaceuticals-logo

Celator Pharmaceuticals

Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.

emmaus-medical-logo

Emmaus Medical

Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.

haihe-biopharma-logo

Haihe Biopharma

Haihe Biopharma is a biopharmaceutical company that develops cancer anti-tumour drugs.

osteal-therapeutics-logo

Osteal Therapeutics

Osteal Therapeutics is a clinical stage specialty pharmaceutical company developing novel treatments for orthopedic infections.

salix-pharmaceuticals-logo

Salix Pharmaceuticals

Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.

scpharmaceuticals-logo

scPharmaceuticals

ScPharmaceuticals is a biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery.

sprout-pharmaceuticals-logo

Sprout Pharmaceuticals

Sprout Pharmaceuticals is a medical company that develops products for the treatment of female sexual dysfunction.


Current Advisors List

frank-jiang_image

Frank Jiang Board Chairman @ CStone Pharmaceuticals
Board_member

Current Employees Featured

frank-jiang_image

Frank Jiang
Frank Jiang CEO @ CStone Pharmaceuticals
CEO

jason-yang_image

Jason Yang
Jason Yang Chief Medical Officer @ CStone Pharmaceuticals
Chief Medical Officer

jon-wang_image

Jon Wang
Jon Wang Chief Scientific Officer @ CStone Pharmaceuticals
Chief Scientific Officer

richard-yeh_image

Richard Yeh
Richard Yeh Chief Financial Officer @ CStone Pharmaceuticals
Chief Financial Officer

Founder


frank-jiang_image

Frank Jiang

Stock Details


Company's stock symbol is HKG:2616

Investors List

oriza-seed-capital_image

Oriza Seed Capital (Oriza Yuandian)

Oriza Seed Capital (Oriza Yuandian) investment in Series B - CStone Pharmaceuticals

hillhouse-capital_image

Hillhouse Capital Group

Hillhouse Capital Group investment in Series B - CStone Pharmaceuticals

taikang-life-insurance_image

Taikang Life Insurance

Taikang Life Insurance investment in Series B - CStone Pharmaceuticals

citic-pe_image

CPE

CPE investment in Series B - CStone Pharmaceuticals

6-dimensions-capital_image

6 Dimensions Capital

6 Dimensions Capital investment in Series B - CStone Pharmaceuticals

arch-venture-partners_image

ARCH Venture Partners

ARCH Venture Partners investment in Series B - CStone Pharmaceuticals

boyu-capital_image

Boyu Capital

Boyu Capital investment in Series B - CStone Pharmaceuticals

sequoia-capital-china_image

Sequoia Capital China

Sequoia Capital China investment in Series B - CStone Pharmaceuticals

king-star-capital_image

King Star Capital

King Star Capital investment in Series B - CStone Pharmaceuticals

yf-capital_image

YF Capital

YF Capital investment in Series B - CStone Pharmaceuticals

Official Site Inspections

http://www.cstonepharma.com Semrush global rank: 1.36 M Semrush visits lastest month: 21.32 K

  • Host name: 203.107.44.133
  • IP address: 203.107.44.133
  • Location: Hangzhou China
  • Latitude: 30.294
  • Longitude: 120.1619
  • Timezone: Asia/Shanghai

Loading ...

More informations about "CStone Pharmaceuticals"

Company Profile-CStone Pharmaceuticals

CStone (HKEX: 2616), established in late 2015, is an innovation-driven biopharmaceutical company focused on the research and development of anti-cancer therapies.See details»

CStone Company Presentation - CSTONE PHARMA

5 Today, CStone has achieved commercialization of multiple products and expanded the global dimensions of its business, establishing its position amongSee details»

CStone Pharmaceuticals - LinkedIn

CStone Pharmaceuticals | 6,840 followers on LinkedIn. CStone (HKEX: 2616) is a biopharmaceutical company focused on researching, developing, and commercializing …See details»

CStone Pharmaceuticals - Crunchbase Company Profile & Funding

Contact Email [email protected] Phone Number + 86-(0)512-8718-6550 CStone Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing …See details»

Cstone Pharmaceuticals Company Profile - China - EMIS

Jul 6, 2024 CStone Pharmaceuticals is a biopharmaceutical company focused on researching, developing, and commercializing innovative immuno-oncology and precision medicines to …See details»

CStone Pharmaceuticals Co Ltd: Overview - GlobalData

Website www.cstonepharma.com Telephone 86 012 60335000. No of Employees 251. Industry Pharmaceuticals and Healthcare. Ticker Symbol & Exchange 2616 (HKG) Revenue (2022) …See details»

CStone Pharmaceuticals - Company Profile and News

Company profile page for CStone Pharmaceuticals including stock price, company news, executives, board members, and contact informationSee details»

CStone Pharmaceuticals Reports 2021 Annual Results and Recent …

May 31, 2022 We have established a full-fledged commercial organization with the capabilities and executional sophistication of multinational company. The leadership team is composed of …See details»

CStone Pharmaceuticals - Craft

CStone Pharmaceuticals has 5 employees across 3 locations and $410 m in total funding,. See insights on CStone Pharmaceuticals including office locations, competitors, revenue, …See details»

CStone Pharmaceuticals (CSPHF) Company Profile & Overview

Jul 26, 2024 CStone Pharmaceuticals, a biopharmaceutical company, researches, develops, and commercializes immuno-oncology and precision medicines to address the unmet medical …See details»

CStone Pharmaceuticals

CStone Pharmaceuticals is a biopharma company focused on developing and commercializing innovative immuno-oncology and molecularly targeted drugs to address significant unmet …See details»

Overview, News & Similar companies - ZoomInfo.com

Who is CStone Pharmaceuticals. CStone Pharmaceuticals (HKEX: 2616) is a biopharmaceutical company focused on researching, developing, and commercializing innovative immuno-oncolo …See details»

CStone Pharmaceuticals Company Overview, Contact Details

Cstonepharma partnered with Bayer on May 1st '19. Similarly, in May 2019, CStone Pharmaceuticals collaborated with Bayer, to evaluate the safety, tolerability, pharmacokinetics, …See details»

INVESTOR RELATIONS-CStone Pharmaceuticals

Your privacy is important for us. We use cookies to enhance your experience when visiting our websites: performance cookies show us how you use this website, functional cookies …See details»

Ewopharma and CStone enter into a Strategic Partnership for …

May 27, 2024 Schaffhausen, Switzerland, 27 th May 2024 – Ewopharma announces today that it has entered into a strategic commercial collaboration with CStone Pharmaceuticals (“CStone”, …See details»

Strategic Collaboration between CStone and Pfizer - CSTONE …

CStone’scapability of building a full-fledged commercial organization with near-term ambitions to reach “critical mass” Importance for the Patient Community Patients to obtain faster and …See details»

2616.HK - | Stock Price & Latest News | Reuters

Nov 23, 2024 Get CStone Pharmaceuticals (2616.HK) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsSee details»

Press Release-CStone Pharmaceuticals

Suzhou, China, January 13th,2022- CStone Pharmaceuticals (“CStone”, HKEX: 2616), a leading biopharmaceutical company focused on research, development, and commercialization of …See details»

CStone and Pharmalink Enter into Strategic Partnership for …

Nov 21, 2024 IR contact: [email protected]. PR contact: [email protected] . About Pharmalink. Pharmalink established in 1993 is a leading company based out of United Arab …See details»

CStone Pharmaceuticals Reports 2023 Annual Results and Business …

Mar 27, 2024 For more information about CStone, please visit www.cstonepharma.com. Forward-looking statements. The forward-looking statements made in this article only relate to …See details»

linkstock.net © 2022. All rights reserved